SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001829126-22-016998
Filing Date
2022-09-20
Accepted
2022-09-20 08:45:20
Documents
13
Period of Report
2022-09-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K organicellregenra_8k.htm   iXBRL 8-K 37274
2 EXHIBT 99.1 organicellregenra_ex99-1.htm EX-99.1 17567
  Complete submission text file 0001829126-22-016998.txt   226988

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ocel-20220920.xsd EX-101.SCH 2965
4 XBRL LABEL FILE ocel-20220920_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE ocel-20220920_pre.xml EX-101.PRE 22363
7 EXTRACTED XBRL INSTANCE DOCUMENT organicellregenra_8k_htm.xml XML 3295
Mailing Address 1951 NW 7TH AVENUE SUITE 300 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 300 MIAMI FL 33136 888-963-7881
Organicell Regenerative Medicine, Inc. (Filer) CIK: 0001557376 (see all company filings)

IRS No.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 000-55008 | Film No.: 221252130
SIC: 3790 Miscellaneous Transportation Equipment